Only a minority of postmenopausal women with surgically treated breast cancer receive adjuvant chemotherapy that consensus guidelines advocate, and its use declines substantially with age.
Dr. Xianglin L. Du, of the University of Texas Medical Branch, Galveston, and colleagues examined data from the New Mexico Tumor Registry for women with stage I, stage II or stage IIIA breast cancer during the period spanning 1991 through 1997. Included were 5101 patients ages 20 to 98.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!